1. Home
  2. HOWL vs MGRM Comparison

HOWL vs MGRM Comparison

Compare HOWL & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • MGRM
  • Stock Information
  • Founded
  • HOWL 2017
  • MGRM 2016
  • Country
  • HOWL United States
  • MGRM United States
  • Employees
  • HOWL N/A
  • MGRM N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • MGRM Medical/Dental Instruments
  • Sector
  • HOWL Health Care
  • MGRM Health Care
  • Exchange
  • HOWL Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • HOWL 87.4M
  • MGRM 89.6M
  • IPO Year
  • HOWL 2021
  • MGRM N/A
  • Fundamental
  • Price
  • HOWL $1.36
  • MGRM $2.78
  • Analyst Decision
  • HOWL Strong Buy
  • MGRM Strong Buy
  • Analyst Count
  • HOWL 2
  • MGRM 1
  • Target Price
  • HOWL $9.50
  • MGRM $4.00
  • AVG Volume (30 Days)
  • HOWL 265.6K
  • MGRM 42.8K
  • Earning Date
  • HOWL 03-06-2025
  • MGRM 03-14-2025
  • Dividend Yield
  • HOWL N/A
  • MGRM N/A
  • EPS Growth
  • HOWL N/A
  • MGRM N/A
  • EPS
  • HOWL N/A
  • MGRM N/A
  • Revenue
  • HOWL $3,386,000.00
  • MGRM $364,999.00
  • Revenue This Year
  • HOWL N/A
  • MGRM N/A
  • Revenue Next Year
  • HOWL $34.17
  • MGRM N/A
  • P/E Ratio
  • HOWL N/A
  • MGRM N/A
  • Revenue Growth
  • HOWL N/A
  • MGRM N/A
  • 52 Week Low
  • HOWL $1.26
  • MGRM $1.53
  • 52 Week High
  • HOWL $8.19
  • MGRM $4.90
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • MGRM 56.50
  • Support Level
  • HOWL $1.26
  • MGRM $2.62
  • Resistance Level
  • HOWL $1.45
  • MGRM $2.87
  • Average True Range (ATR)
  • HOWL 0.09
  • MGRM 0.14
  • MACD
  • HOWL 0.02
  • MGRM 0.00
  • Stochastic Oscillator
  • HOWL 45.45
  • MGRM 73.09

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: